TCR engagement negatively affects CD8 but not CD4 CAR T cell expansion and leukemic clearance. 2017

Yinmeng Yang, and M Eric Kohler, and Christopher D Chien, and Christopher T Sauter, and Elad Jacoby, and Chunhua Yan, and Ying Hu, and Kelsey Wanhainen, and Haiying Qin, and Terry J Fry
Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Chimeric antigen receptor (CAR)-expressing T cells induce durable remissions in patients with relapsed/refractory B cell malignancies. CARs are synthetic constructs that, when introduced into mature T cells, confer a second, non-major histocompatibility complex-restricted specificity in addition to the endogenous T cell receptor (TCR). The implications of TCR activation on CAR T cell efficacy has not been well defined. Using an immunocompetent, syngeneic murine model of CD19-targeted CAR T cell therapy for pre-B cell acute lymphoblastic leukemia in which the CAR is introduced into T cells with known TCR specificity, we demonstrate loss of CD8 CAR T cell efficacy associated with T cell exhaustion and apoptosis when TCR antigen is present. CD4 CAR T cells demonstrate equivalent cytotoxicity to CD8 CAR T cells and, in contrast, retain in vivo efficacy despite TCR stimulation. Gene expression profiles confirm increased exhaustion and apoptosis of CD8 CAR T cells upon dual receptor stimulation compared to CD4 CAR T cells and indicate inherent differences between CD4 and CD8 CAR T cells in the use of T cell-associated signaling pathways. These results provide insights into important aspects of CAR T cell immune biology and indicate opportunities to rationally design CAR constructs to optimize clinical efficacy.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D011946 Receptors, Antigen Molecules on the surface of B- and T-lymphocytes that recognize and combine with specific antigens. Antigen Receptors,Antigen Receptor,Receptor, Antigen
D011948 Receptors, Antigen, T-Cell Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Antigen Receptors, T-Cell,T-Cell Receptors,Receptors, T-Cell Antigen,T-Cell Antigen Receptor,T-Cell Receptor,Antigen Receptor, T-Cell,Antigen Receptors, T Cell,Receptor, T-Cell,Receptor, T-Cell Antigen,Receptors, T Cell Antigen,Receptors, T-Cell,T Cell Antigen Receptor,T Cell Receptor,T Cell Receptors,T-Cell Antigen Receptors
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis

Related Publications

Yinmeng Yang, and M Eric Kohler, and Christopher D Chien, and Christopher T Sauter, and Elad Jacoby, and Chunhua Yan, and Ying Hu, and Kelsey Wanhainen, and Haiying Qin, and Terry J Fry
January 1989, International journal of cancer. Supplement = Journal international du cancer. Supplement,
Yinmeng Yang, and M Eric Kohler, and Christopher D Chien, and Christopher T Sauter, and Elad Jacoby, and Chunhua Yan, and Ying Hu, and Kelsey Wanhainen, and Haiying Qin, and Terry J Fry
January 1997, Journal of immunology (Baltimore, Md. : 1950),
Yinmeng Yang, and M Eric Kohler, and Christopher D Chien, and Christopher T Sauter, and Elad Jacoby, and Chunhua Yan, and Ying Hu, and Kelsey Wanhainen, and Haiying Qin, and Terry J Fry
July 1993, Immunology letters,
Yinmeng Yang, and M Eric Kohler, and Christopher D Chien, and Christopher T Sauter, and Elad Jacoby, and Chunhua Yan, and Ying Hu, and Kelsey Wanhainen, and Haiying Qin, and Terry J Fry
March 2017, Journal of immunology (Baltimore, Md. : 1950),
Yinmeng Yang, and M Eric Kohler, and Christopher D Chien, and Christopher T Sauter, and Elad Jacoby, and Chunhua Yan, and Ying Hu, and Kelsey Wanhainen, and Haiying Qin, and Terry J Fry
July 2003, International immunology,
Yinmeng Yang, and M Eric Kohler, and Christopher D Chien, and Christopher T Sauter, and Elad Jacoby, and Chunhua Yan, and Ying Hu, and Kelsey Wanhainen, and Haiying Qin, and Terry J Fry
December 2002, Nature immunology,
Yinmeng Yang, and M Eric Kohler, and Christopher D Chien, and Christopher T Sauter, and Elad Jacoby, and Chunhua Yan, and Ying Hu, and Kelsey Wanhainen, and Haiying Qin, and Terry J Fry
February 2006, Immunological reviews,
Yinmeng Yang, and M Eric Kohler, and Christopher D Chien, and Christopher T Sauter, and Elad Jacoby, and Chunhua Yan, and Ying Hu, and Kelsey Wanhainen, and Haiying Qin, and Terry J Fry
August 2001, Journal of molecular medicine (Berlin, Germany),
Yinmeng Yang, and M Eric Kohler, and Christopher D Chien, and Christopher T Sauter, and Elad Jacoby, and Chunhua Yan, and Ying Hu, and Kelsey Wanhainen, and Haiying Qin, and Terry J Fry
August 2007, Journal of immunology (Baltimore, Md. : 1950),
Yinmeng Yang, and M Eric Kohler, and Christopher D Chien, and Christopher T Sauter, and Elad Jacoby, and Chunhua Yan, and Ying Hu, and Kelsey Wanhainen, and Haiying Qin, and Terry J Fry
December 2020, Immunology,
Copied contents to your clipboard!